ArticleInvestigative ophthalmology & visual science2026
Role of Programmed Cell Death Pathways in Mediating Epithelial Wound Healing and Its Defects in Diabetic Corneas.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Purpose: Diabetic keratopathy (DK), a sight-threatening corneal disease, is characterized by delayed epithelial wound healing and ulceration. This study investigated the role of programmed cell death (PCD) pathways-caspase-mediated apoptosis and RIPK1/RIPK3-mediated necroptosis-in corneal wound healing in normal (NL) and diabetes mellitus (DM) B6 mice. Methods: Corneal epithelial debridement wounds were created in normoglycemic, streptozotocin (STZ)-induced, and db/db diabetic mice. Wound closure was quantified by digitizing the residual wound area. PCD pathway activity was assessed by RT-qPCR, immunohistochemistry (IHC), and whole-mount confocal microscopy. Pharmacologic inhibitors were applied to determine the role of specific PCD modulators in corneal wound healing. Results: In healing DM corneas, wounding-induced Casp8 upregulation was blunted, whereas RIPK3 upregulation was enhanced. At the tissue level, cleaved caspase-3 (c-Casp3, active) was more abundant in NL corneas, whereas phosphorylated RIPK3 (pRIPK3) predominated in DM corneas. The pRIPK3 was detected as early as 9 hours post-wounding in DM corneas, whereas c-Casp3 was most abundant at 72 hours post-wounding-a time point when PCD activity was no longer detectable in NL corneas. Pharmacologic inhibition of RIPK3 accelerated wound closure and suppressed inflammation in both NL and DM corneas, with greater benefit in DM corneas. Notably, extracellular HMGB1, a key alarmin/DAMP released during necroptosis, was strongly localized to basal cells. Blocking HMGB1 with glycyrrhizin, a cell-impermeable inhibitor, improved wound healing outcomes in DM corneas. Conclusions: Hyperglycemia skews PCD from apoptosis toward necroptosis. Targeting necroptosis or its downstream effectors, such as HMGB1, may represent a promising therapeutic approach for DK.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.